MedVellum
MedVellum
Back to Library
Gastroenterology
Oncology
Upper GI Surgery

Oesophageal Cancer

High EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Progressive dysphagia (solids then liquids)
  • Weight loss
  • Hoarseness (recurrent laryngeal nerve palsy)
  • Systemic symptoms
Overview

Oesophageal Cancer

1. Clinical Overview

Summary

Oesophageal cancer is a malignancy of the oesophagus with two main histological types: adenocarcinoma (lower third, associated with Barrett's oesophagus, obesity, and GORD) and squamous cell carcinoma (middle/upper third, associated with smoking and alcohol). The cardinal symptom is progressive dysphagia - initially for solids, then liquids - often accompanied by weight loss. Prognosis is generally poor due to late presentation, with 5-year survival around 15-20%. Diagnosis is by upper GI endoscopy with biopsy. Curative treatment (oesophagectomy with or without neoadjuvant chemotherapy) is possible in early stages; palliative options include stenting and radiotherapy.

Key Facts

  • Types: Adenocarcinoma (lower 1/3; Barrett's, obesity) vs Squamous (middle/upper; smoking, alcohol)
  • Symptoms: Progressive dysphagia, Weight loss, Hoarseness, Odynophagia
  • Investigation: Urgent OGD + Biopsy
  • Staging: CT, EUS, PET-CT
  • Treatment: Oesophagectomy +/- neoadjuvant chemo (curative); Stenting (palliative)
  • Prognosis: Poor overall (5-year survival ~15-20%)

Clinical Pearls

"Solids Before Liquids": Progressive dysphagia starting with solids then liquids is classic for a mechanical obstruction (cancer). Immediate difficulty with both suggests motility disorder.

"Barrett's Is the Precursor for Adenocarcinoma": Long-standing GORD → Barrett's (intestinal metaplasia) → Dysplasia → Adenocarcinoma.

"Upper = Squamous, Lower = Adeno": Squamous cell carcinoma in upper/middle oesophagus; adenocarcinoma in lower oesophagus/GOJ.

"Hoarseness = Bad Sign": Hoarse voice suggests recurrent laryngeal nerve involvement - usually indicates incurable disease.


2. Epidemiology

Incidence

  • ~9,000 cases/year in UK
  • 6th most common cause of cancer death

Demographics

  • M:F = 3:1
  • Peak age: 60-80 years
  • Adenocarcinoma: Increasing (linked to obesity)
  • Squamous: Decreasing (linked to smoking decline)

Risk Factors

AdenocarcinomaSquamous Cell
Barrett's oesophagusSmoking
GORDAlcohol
ObesityHot beverages (some regions)
Male sexAchalasia
CaucasianPlummer-Vinson syndrome
Coeliac disease (historical)

3. Pathophysiology

Adenocarcinoma Sequence

  1. GORD → Chronic acid exposure
  2. Barrett's oesophagus → Intestinal metaplasia
  3. Low-grade dysplasia
  4. High-grade dysplasia
  5. Adenocarcinoma

Squamous Cell Carcinoma

  • Arises from squamous epithelium
  • Chronic irritation (alcohol, smoking, heat) → Dysplasia → Cancer

Spread

  • Local: Mediastinal structures, trachea, aorta
  • Lymphatic: Upper/mid → Cervical; Lower → Coeliac nodes
  • Haematogenous: Liver, Lungs, Bone

4. Clinical Presentation

Symptoms

SymptomNotes
DysphagiaProgressive; solids → liquids
Weight lossOften significant
OdynophagiaPainful swallowing
RegurgitationUndigested food
HoarsenessRLN involvement (advanced)
CoughAspiration or tracheal fistula
Chest painRetrosternal

Late/Advanced Features


Cervical lymphadenopathy (Virchow's node)
Common presentation.
Hepatomegaly (metastases)
Common presentation.
Ascites
Common presentation.
Bone pain
Common presentation.
5. Clinical Examination

General

  • Cachexia
  • Pallor (anaemia)
  • Dehydration

Specific

  • Supraclavicular lymphadenopathy (especially left - Virchow's node)
  • Hepatomegaly
  • Ascites

Voice

  • Hoarse (recurrent laryngeal nerve palsy)

6. Investigations

Diagnosis

TestNotes
Upper GI Endoscopy (OGD)Direct visualisation + biopsy; Gold standard
HistologyAdenocarcinoma or Squamous cell

Staging

TestPurpose
CT Chest/AbdomenDistant metastases
EUS (Endoscopic Ultrasound)T and N staging (depth of invasion)
PET-CTDetect occult metastases
Staging LaparoscopyFor GOJ tumours (peritoneal disease)

Additional

  • Bloods: FBC (anaemia), U&E, LFTs, Albumin
  • Nutritional assessment

7. Management

Management Approach

┌──────────────────────────────────────────────────────────┐
│   OESOPHAGEAL CANCER MANAGEMENT                          │
├──────────────────────────────────────────────────────────┤
│                                                          │
│  CURATIVE INTENT (Early stage, fit patient):             │
│  • Neoadjuvant chemotherapy or chemoradiotherapy         │
│  • Oesophagectomy (Ivor Lewis, McKeown, transhiatal)     │
│  • Resection + nodal dissection                          │
│                                                          │
│  EARLY CANCER/DYSPLASIA (T1a):                            │
│  • Endoscopic mucosal resection (EMR)                    │
│  • Endoscopic submucosal dissection (ESD)                │
│  • Ablation (RFA) for Barrett's with HGD                 │
│                                                          │
│  PALLIATIVE (Advanced/Metastatic):                        │
│  • Oesophageal stenting (SEMS) for dysphagia             │
│  • Palliative radiotherapy                               │
│  • Palliative chemotherapy                               │
│  • Nutritional support (NG/PEG/Jejunostomy)              │
│  • Best supportive care                                  │
│                                                          │
│  MDT DISCUSSION:                                          │
│  • All cases discussed at Upper GI MDT                   │
│  • Oncology, Surgery, Radiology, Pathology, CNS          │
│                                                          │
└──────────────────────────────────────────────────────────┘

Oesophagectomy

  • Ivor Lewis: Right thoracotomy + laparotomy; anastomosis in chest
  • McKeown: Three-stage; cervical anastomosis
  • Transhiatal: Avoids thoracotomy

8. Complications

Of Disease

  • Complete obstruction (unable to swallow saliva)
  • Aspiration pneumonia
  • Tracheo-oesophageal fistula
  • Massive haemorrhage (aortic erosion)
  • Malnutrition

Of Treatment

  • Oesophagectomy: Anastomotic leak, stricture, recurrent laryngeal nerve injury, pneumonia
  • Stent: Migration, perforation, tumour overgrowth

9. Prognosis & Outcomes

Survival

Stage5-Year Survival
Stage I40-60%
Stage II20-40%
Stage III10-20%
Stage IV<5%

Overall

  • Overall 5-year survival: 15-20%
  • Poor prognosis due to late presentation

Prognostic Factors

  • Stage at diagnosis (most important)
  • Tumour grade
  • Performance status
  • Response to neoadjuvant therapy

10. Evidence & Guidelines

Key Guidelines

  1. NICE NG83: Oesophago-gastric Cancer (2018)
  2. ESMO Clinical Practice Guidelines
  3. BSG Guidelines: Barrett's Oesophagus

Key Evidence

Neoadjuvant Chemoradiotherapy

  • CROSS trial: Improved survival vs surgery alone

Barrett's Surveillance

  • Reduces cancer mortality

11. Patient/Layperson Explanation

What is Oesophageal Cancer?

Oesophageal cancer is cancer of the food pipe (oesophagus), which connects your throat to your stomach.

What Are the Types?

  • Adenocarcinoma: Usually in the lower oesophagus; linked to acid reflux, Barrett's oesophagus, and being overweight
  • Squamous cell carcinoma: Usually in the upper/middle; linked to smoking and alcohol

What Are the Symptoms?

  • Difficulty swallowing (food gets stuck, starting with solids then liquids)
  • Weight loss
  • Heartburn that doesn't go away
  • Hoarse voice
  • Bringing food back up

How is it Diagnosed?

An endoscopy (camera down your throat) is used to look at the oesophagus and take samples (biopsies).

How is it Treated?

  • Early cancer: May be removed with an endoscopy or surgery
  • More advanced cancer: Surgery to remove part of the oesophagus, often with chemotherapy before
  • If it can't be cured: A stent can be placed to help you swallow; radiotherapy and chemotherapy can control symptoms

What's the Outlook?

It depends on how early the cancer is found. If caught early, outcomes are good. Unfortunately, many cancers are found late, which makes treatment more difficult.


12. References

Primary Guidelines

  1. NICE. Oesophago-gastric Cancer: Assessment and Management in Adults (NG83). 2018. nice.org.uk/guidance/ng83

Key Studies

  1. van Hagen P, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer (CROSS trial). N Engl J Med. 2012;366(22):2074-2084. PMID: 22646630

Last updated: 2025-12-22

At a Glance

EvidenceHigh
Last Updated2025-12-22

Red Flags

  • Progressive dysphagia (solids then liquids)
  • Weight loss
  • Hoarseness (recurrent laryngeal nerve palsy)
  • Systemic symptoms

Clinical Pearls

  • **"Solids Before Liquids"**: Progressive dysphagia starting with solids then liquids is classic for a mechanical obstruction (cancer). Immediate difficulty with both suggests motility disorder.
  • **"Barrett's Is the Precursor for Adenocarcinoma"**: Long-standing GORD → Barrett's (intestinal metaplasia) → Dysplasia → Adenocarcinoma.
  • **"Upper = Squamous, Lower = Adeno"**: Squamous cell carcinoma in upper/middle oesophagus; adenocarcinoma in lower oesophagus/GOJ.
  • **"Hoarseness = Bad Sign"**: Hoarse voice suggests recurrent laryngeal nerve involvement - usually indicates incurable disease.

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines